Form 4: Neogen Corp Director Catherine Woteki Reports Stock Transaction

Director Catherine Woteki reported the vesting and settlement of Restricted Stock Units (RSUs) into common stock of Neogen Corp on October 28, 2024.

Summary

• On October 29, 2024, a Form 4 filing was submitted to the SEC by Christopher Sefcheck, Attorney in Fact, on behalf of Catherine E Woteki, a director of Neogen Corp.
• The report details a transaction that occurred on October 28, 2024, involving the vesting and settlement of Restricted Stock Units (RSUs).
• Specifically, 1,776 RSUs vested and were settled for an equal number of shares of Neogen Corp common stock at a price of $13.81.
• Following the transaction, Woteki directly owns 7,474 shares of Neogen Corp common stock and 3,552 derivative securities.
• The RSUs are the economic equivalent of one share of common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings of company directors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director's holdings.

Key Dates